APA (7th ed.) Citation

Cheng, P., Mo, L., Chen, C., Chen, C., Huang, C., Kuo, H., . . . Chang, T. S. (2022). Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan. Infectious Diseases & Therapy, 11(1), 485. https://doi.org/10.1007/s40121-021-00576-7

Chicago Style (17th ed.) Citation

Cheng, Pin-Nan, et al. "Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan." Infectious Diseases & Therapy 11, no. 1 (2022): 485. https://doi.org/10.1007/s40121-021-00576-7.

MLA (9th ed.) Citation

Cheng, Pin-Nan, et al. "Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan." Infectious Diseases & Therapy, vol. 11, no. 1, 2022, p. 485, https://doi.org/10.1007/s40121-021-00576-7.